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INTRODUCTION 
 
Tuberculosis has co-existed with humanity since the days before 
recorded history and evidence of tuberculosis has been found in the skeletal 
remains of mummies 1. Hippocrates not only described the disease but also 
named it ‘phthisis’ which means to mart or waste away.  
 Tuberculosis remains a major global public health problem. Roughly a 
third of the world's population has been infected with M. tuberculosis, and 
new infections occur at a rate of one per second. However, not all infections 
with M. tuberculosis cause TB disease and many infections are 
asymptomatic.  As per WHO 2009 report, in 2008, there were an estimated 
8.9-9.9 million incident cases of Tuberculosis 64, 9.6-13.3 million prevalent 
cases of Tuberculosis 1.1-1.7 million deaths from Tuberculosis. 
  India had the largest total incidence, with an estimated 2.0 million new 
cases. India has the most number of cases of tuberculosis and accounts for 
about one-fifth of the global TB burden and 2/3th of the South –East Asian 
countries burden.  Nearly 40% of the Indian population is affected with 
tuberculosis bacillus. Each year, 1.9 million cases of TB are detected, 
amongst which 0.8 million are smear positive new cases (infectious cases) 62.   
Daily, nearly 1000 people die due to TB (2 deaths/ 3 minutes).  As per WHO 
estimate, there were nearly 322,000 TB deaths in 2006 in India which 
accounted for 26% of all the preventable adult deaths. 
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Socio –economic burden in India – Apart from the considerable 
morbidity and mortality it causes, TB imparts a great socio – economic 
burden on India. TB affects people in the age group which is most productive 
in the population (15-54 years).  This disease is even more common among 
the poorer section of the community and those with a lower socio-economic 
status.  Two-third of the affected population is males, and more than 50% of 
affected females are below the age of 34.   
Tuberculosis, a reemerging killer, is threatening to assume serious 
proportion all over the world, particularly in view of the AIDS pandemic. 
Extra -pulmonary tuberculosis is on the increase world over. In countries 
with good surveillance data like the USA, where the rate of pulmonary 
tuberculosis has declined to its lowest levels ever in 2001 statistics indicate a 
relative increase of extra-pulmonary cases from 16% in 1992 to 20% in 
20009, while its prevalence is 15-30% in immuno-competent persons. 
 In India, EPTB comprises 20% of all TB cases. Its prevalence in the 
country varies between 8.3-13.1% in different districts according to cohort 
analysis by Central TB Division, Ministry of Health & Family Welfare in 
200213.  In the year 2006, 1,83,180 EPTB cases were registered in 
comparison to 5,55,660 smear positive pulmonary TB cases giving a ratio of 
1:0.24 to 1:0.06. Cure of infectious cases is likely to have resulted in a 
relative rise of annual EPTB case detection13. Prevalence of EPTB has also 
been found to be higher in pediatric cases7. 
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Extra pulmonary tuberculosis can occur alone or in combination with 
the pulmonary Tuberculosis. It is usually confined to a single site but 
disseminated form may also occur. Tuberculosis of meninges, spine, nervous 
system, abdomen, pleura, pericardium, bones and joints are considered severe 
forms compared to other sites. 
Diagnosis of extra pulmonary tuberculosis is difficult. The diagnosis is 
confirmed by demonstrating AFB using conventional microscopy which is 
specific and rapid but its sensitivity is less. The microscopy detects positive 
smear if at least 10000 bacilli be present per ml of sample and culture 
isolation is possible only if 10-100 bacilli is present. 
 While culture is more sensitive and specific it takes 6 weeks to get the 
results. The specimen being a paucibacillary condition, the yield of positive 
culture has not been high.  However using appropriate concentration 
techniques, multiple medias, and subculture it is made possible to increase 
the isolation rate in culture. 
However, the rapid methods like, radiometric growth detection system 
in liquid medium and recent molecular techniques such as polymerase chain 
reaction and restricted fragment length polymorphism (RFLP) have high 
sensitivity and play a major role in diagnosis of extra pulmonary tuberculosis. 
PCR techniques involve a number of different targets including IS6110 
insertion sequences. The Insertion sequence of IS6110 is a mobile genetic 
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element and has universal acceptance, since it is found only in 
mycobacterium tuberculosis complex, M.tuberculosis strain carries multiple 
copies of the element. Hence this study compares conventional methods with 
rapid molecular detection of mycobacterium tuberculosis in extra pulmonary 
specimens. 
The World Health Organisation defines Multi-Drug Resistant 
TB (MDR-TB) as resistance to at least two of the first line drugs 
used: rifampicin and ionized. It is, by and large, caused when patients default 
on treatment, though it is also known to be caused by spontaneous mutation 
of the bacteria as well. The world is also concerned now about XDR-TB or 
extensively Drug Resistant TB, a subset of MDR-TB also resistant to 
fluoroquinolones and one of the three injectables, Kanamycin, Capreomycin 
and Amikacin. XDR-TB has been noted as an emerging health threat, 
especially in countries like India, with a high prevalence of HIV. 
Tuberculosis Control India, the wing of the Union Ministry of Health that 
implements the Revised National Tuberculosis Control Programme 
(RNTCP), indicates that MDR-TB levels in the country are about three per 
cent in new cases and 12-17 per cent in re-treatment cases. 
 WHO said drug-resistant TB spreading faster than ever.  Globally 
there are 500,000 new cases of drug resistance TB every year, about five per 
cent of the nine million new TB cases.62 
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Data on drug sensitivity pattern would need to be generated to facilitate 
formulation of proper treatment polices which I have included in my study. 
Prompt and accurate diagnosis and effective treatment are essential for good 
patient care and also help in effective treatment of tuberculosis control36.     
 
 
 
 
 
 
 
 
 
 
 
 
  
6 
 
 
 
AIMS AND OBJECTIVE 
 
 
 
 Study of prevalence of  extra pulmonary tuberculosis in a Tertiary Care 
Hospital, Chennai 
 
 Comparison of smear by Ziehl-Neelsen and Auramine Phenol 
Fluorescence Staining  
 
 Isolation of Mycobacterium in Extra Pulmonary specimens by 
employing conventional bacteriological methods. 
 
 Comparison of culture by Kirchner’s and Lowenstein-Jensen Medium 
 
 Identification of Mycobacteria by employing standard phenotypic 
methods. 
 
 Performing drug susceptibility on the isolates identified as 
Mycobacterium tuberculosis. 
 
 Comparison of conventional methods with molecular method IS 6110 
based Polymerase Chain Reaction. 
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REVIEW OF LITERATURE 
 
TUBERCULOSIS 
Tuberculosis, one of the oldest diseases known to affect humans is 
caused by the bacteria, Mycobacterium tuberculosis complex. The disease 
usually affects the lungs, although in up to one third of the cases other organs 
are also involved.  If properly treated, virtually all cases of tuberculosis are 
curable. If untreated, the disease may be fatal within five years in more than 
half of the cases.  Transmission usually takes place through the air borne 
spread of droplet nuclei produced by patients with pulmonary tuberculosis. 
 
HISTORY  
Robert Koch first identified the tubercle bacilli in 188253. In his classic 
reports he defined the staining procedures for the direct observation of bacilli 
in clinical specimen. Culture techniques on solid medium for the in-vitro 
passage of bacilli isolated from clinical or experimental lesions and 
subsequent inoculation of guinea pigs with cultural materials to confirm its 
etiologic role in tuberculosis.  This became the basis of ‘Koch’s postulates’ 
the standard criteria for etiologic research in infectious diseases. 
Tuberculosis lymphadenitis is the commonest type of TB described in 
Hippocrates writing dating back to 460-377 BC.  It was initially thought to be 
cured by the touch of the king (King’s evil) in Europe.         
8 
 
ETIOLOGIC AGENT 
Mycobacteria belong to the Family: ‘Mycobacteriaceae’ and the order 
‘Actinomyectales’ The name ‘Mycobacterium’ was given to this genus by 
Lehmann and Neumann in 1896 on account of the mould like pellicles 
produced by these bacteria when grown in liquid media.   
There are about 100 mycobacterial species.  The term tubercle bacilli 
broadly include the species of mycobacteria which gives rise to tuberculosis 
in man. These are M. Bovis,   M. africanum ,  M. tuberculosis,  M. microti 
and M .carnetti17. 
The most frequent and important agent of human disease is 
mycobacterium tuberculosis.  It is a thin rod shaped, non-capsulated non-
sporing aerobic, bacteria measuring about 0.5μm/3μm in size acid fast and 
non-motile. 
An important character of mycobacteria is their ability to resist 
decolorization by a weak mineral acid such as 20% sulphuric acid or 3% 
hydrochloric acid after being stained by an arylmethane dye such as basic 
fuschin with which it form stable complexes.  This is acid fastness and it is 
due to the presence of mycolic acid in their cell wall. 
Upon culture, on Lowenstein Jensen media Mycobacterium 
tuberculosis form the rough, tough and buff colored colonies after an average 
incubation period of 2-4 weeks. On liquid kirchner s media which is 
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incubated up to a maximum period of six weeks, mycobacteria form fine 
granular growth. 
CELL WALL STRUCTURE  
The cell wall structure of Mycobacterium tuberculosis deserves special 
attention because it is unique among prokaryotes, and it is a major 
determinant of virulence for the bacterium. The cell wall complex contains 
peptidoglycan, but otherwise it is composed of complex lipids. Over 60% of 
the mycobacterial cell wall is lipid. The lipid fraction of MTB's cell wall 
consists of three major components, mycolic acids, cord factor and wax-D. 
 Mycolic acids are unique alpha-branched lipids found in cell 
walls of Mycobacterium and Corynebacterium. They make up 50% of the dry 
weight of the mycobacterial cell envelope.  Mycolic acids are strong 
hydrophobic molecules that form a lipid shell around the organism and affect 
permeability properties at the cell surface.  Mycolic Acids are thought to be a 
significant determinant of virulence in MTB. Probably, they prevent attack of 
the mycobacteria by cationic proteins, lysozyme, and oxygen radicals in the 
phagocytic granule. They also protect extracellular mycobacteria from 
complement deposition in serum.  
Cord Factor 63 is responsible for the serpentine cording mentioned 
above. Cord factor is toxic to mammalian cells and is also an inhibitor of 
10 
 
PMN migration. Cord factor is most abundantly produced in virulent strains 
of MTB. Wax-D in the cell envelope is the major component of Freund's 
complete adjuvant (CFA).  
EPIDEMIOLOGY   
Epidemiological studies on tuberculosis are concerned with the 
transmission of the disease in the community and the impact of the control 
measures. It is estimated that there were 8.8 million new cases of tuberculosis 
in 2002 of which 3.9 million   were smear positive. The global incidence rate 
of tuberculosis is growing at approximately 1.1% per year and the number of 
cases at 2.4% per year. 
According to WHO, estimates reach 16-20 million cases of 
tuberculosis worldwide in 2001.It is estimated that about one third of the 
current global population is infected asymptomatically with tuberculosis of 
whom 5-10 percent t will develop clinical disease during their lifetime. Most 
new cases and deaths occur and developing countries where infection in often 
acquired in childhood. 
India accounts for nearly one – third of global burden of tuberculosis57. 
Every year, approximately 1.8 million persons developing tuberculosis of 
which about 0.8 million are new smear positive highly infection cases and 
about 4.1 lakh people die of TB every year.  One person dies every minute. 
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 The incidence of TB in HIV infected persons is more than 100 times 
that of the general population.  One of the most threatening features of TB in 
HIV infected patients has been the spread of multidrug - resistant (MDR) 
organisms.  The national AIDS policy documents from Govt. of India show 
that > 60% of AIDS patients suffer from TB as an opportunistic infection. 
 
SOURCE OF INFECTION:  
It is well established that, sputum positive patients i.e. positive on 
direct microbiological examination and thus contains at least 10000 bacilli in 
1 ml and who has either received no treatment or not being treated fully, can 
discharge the bacilli in their sputum for years. They become the potential 
sources of infection. 
 
TRANSMISSION AND DEVELOPMENT OF DISEASE 
Almost all M. tuberculosis infection is acquired by the inhalation of 
aerosolized droplet nuclei (1-5μm), which reach the pulmonary alveoli.  The 
probability that a person will become infected depends upon the duration of 
exposure to the source, the size of the bacillary inoculums inhaled, and the 
infectivity of the Mycobacterial strain. The probability of an immuno-
competent host developing active TB after M. tuberculosis infection is 5-10% 
over the person’s lifetime. Patients with extra pulmonary tuberculosis or 
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smear negative tuberculosis constitute a minimal hazard for transmissions of 
infections. 
 The development of disease depends upon the closeness of the 
contact, extent of disease, sputum positively of the source case and host 
parasite relationship. Thus the incubation period may be weeks, months or 
year.  
 
MYCOBACTERIUM TUBERCULOSIS COMPLEX  
The term M. tuberculosis complex refers to a group of very closely 
related species. All of them cause tuberculosis, a chronic granulomatous 
disease affecting man and many other mammals. 
M. tuberculosis - causes human infection 
M. bovis - affects cattle and other mammals 
M. microti - pathogen of voles and other smaller mammals 
M. africanum - intermediate between human & bovine types. 
 
NON- TUBERCULOUS MYCOBACTERIA 
During the early 1950s, after it had become routine practice to culture 
clinical specimen for M. tuberculosis, it was realized that other mycobacteria 
can also cause disease in human. These organisms became known 
collectively as non-tuberculous mycobacteria. The non-tuberculous 
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mycobacteria, especially the Mycobacterium avium complex and M. 
scrofulaceum should be kept in mind in the HIV millennium. 
 
EXTRAPULMONARY TUBERCULOSIS 
Extra-pulmonary tuberculosis refers to disease outside the lungs, in 
developed countries, 10-15% of TB cases have extra-pulmonary 
involvement, but in patients from high-incidence countries the rate is much 
higher. People who are HIV positive and infected with TB develop extra-
pulmonary disease much more frequently, up to 50% of cases.  
TUBERCULOUS PLEURAL EFFUSION 
 The current hypothesis for the pathogenesis of primary tuberculous 
pleural effusion is that a subpleural caseous focus in the lung ruptures into the 
pleural space6–12 weeks after a primary infection49. Mycobacterial antigens 
enter the pleural space and interact with T-cells previously sensitized to 
mycobacteria, resulting in a delayed hypersensitivity reaction and the 
accumulation of fluid. It seems that this reaction of the pleura augments the 
entry of fluid into the pleural space by increasing the permeability of pleural 
capillaries to serum proteins 28, and thereby increasing the oncotic pressure in 
the pleural fluid. Involvement of the lymphatic system probably also 
contributes to the accumulation of pleural fluid. An impaired clearance of 
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proteins from the pleural space has been reported in human tuberculous 
effusions 26. It is known that the clearance of proteins and fluid from the 
pleural space is carried out by lymphatics in the parietal pleura. Fluid gains 
access to the lymphatics through openings in the parietal pleura called 
stomata60. Since the parietal pleural is diffusely affected with pleural 
tuberculosis, damage to or obstruction of the stomata could be an important 
mechanism leading to accumulation of pleural fluid. 
 
TUBERCULOSIS OF ABDOMEN 
 
The postulated mechanisms by which the tubercule bacilli reach the 
gastrointestinal tract are: (i) hematogenous spread from the primary lung 
focus in childhood, with later reactivation;  (ii) ingestion of bacilli in sputum 
from active pulmonary focus; (iii) direct spread from adjacent organs; and 
(iv) through lymph channels from infected nodes. The earlier belief that most 
cases are due to reactivation of quiescent foci is being challenged with a 
recent study using DNA fingerprinting showing that 40 per cent cases are due 
to reinfection. In India, the organism isolated from all intestinal lesions has 
been Mycobacterium tuberculosis and not M.bovis. The most common site of 
involvement is the ileocaecal region, possibly because of the increased 
physiological stasis, increased rate of fluid and electrolyte absorption, 
minimal digestive activity and an abundance of lymphoid tissue at this site. 
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TUBERCULOUS  MENINGITIS   
 
 
TBM accounts for 70 to 80 per cent of cases of neurological 
tuberculosis 41,54,51. A majority of cases of TBM are caused by M. 
tuberculosis. Isolated cases of meningitis caused by NTM have also been 
documented86. Neurological tuberculosis is invariably secondary to 
tuberculosis elsewhere in the body. In the bacteraemic phase of primary lung 
infection, metastatic foci can get established in any organ, which can become 
active after a variable period of clinical latency. The critical event in the 
development of meningitis is the rupture of a subependymally located 
tubercle (Rich focus) resulting in the release of infectious material into the 
subarachnoid space43. The following features comprise the salient 
pathological features of TBM: (i) inflammatory meningeal exudate;  
(ii)ependymitis; (iii) vasculitis; (iv) encephalitis; and (v) disturbance of 
cerebrospinal fluid (CSF) circulation and absorption.  
 
GENTIOURINARY TUBERCULOSIS 
 
Genitourinary tuberculosis (GUTB) complicates three to four per cent 
of patients with pulmonary tuberculosis19,52,61,30. Haematogenous 
dissemination from an active site of infection results in GUTB. Initially 
metastatic lesions (tubercles) are formed in the kidneys. Macroscopic 
progression of the disease is often unilateral24. Usually, these lesions heal 
spontaneously or as a result of treatment. However, they may enlarge even 
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after years of inactivity and rupture into the nephrons producing bacilluria. 
There is descending spread of infection, inflammation and scarring. Active 
GUTB usually develops 5 to 25 yr after the primary pulmonary infection and 
is usually encountered between the second and fourth decades of life. Patients 
present with dysuria, haematuria which may be painless, flank pain, renal 
mass, sterile pyuria, and recurrent urinary tract infection. Rarely, acute 
presentation mimicking pyelonephritis has also 
been described. Other uncommon presentations include: non healing wounds, 
sinuses or fistulae, haemospermia among others. 
 
COLD ABSCESS 
Scrofula is the term used for tuberculosis of the neck, or, more 
precisely, a cervical tuberculous lymphadenopathy. Scrofula is usually a 
result of an infection in the lymph nodes, known as lymphadenitis and is 
most often observed in immuno compromised patients (about 50% of cervical 
tuberculous lymphadenopathy). About 95% of the scrofula cases in adults are 
caused by Mycobacterium tuberculosis, but only 8% of cases in children. The 
rest are caused by atypical mycobacterium (Mycobacterium scrofulaceum) or 
nontuberculous mycobacterium (NTM). With the stark decrease of 
tuberculosis in the second half of the 20th century, scrofula became a very 
rare disease. With the appearance of AIDS, however, it has shown a 
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resurgence, and presently affects about 5% of severely immunocompromised 
patients. 
SIGNS AND SYMPTOMS 
The most usual signs and symptoms are the appearance of a chronic, 
painless mass in the neck, which is persistent and usually grows with time. 
The mass is referred to as a "cold abscess", because there is no accompanying 
local color or warmth and the overlying skin acquires a violaceous (bluish-
purple) color. NTM infections do not show other notable constitutional 
symptoms, but scrofula caused by tuberculosis is usually accompanied by 
other symptoms of the disease, such as fever, chills, malaise and weight loss 
in about 43% of the patients.  
Both during the initial (or primary) infection with TB and during any 
subsequent secondary active disease the bacteria are spread by blood or the 
lymphatic system to other parts of the body. In healthy people these bacteria 
are usually destroyed by the immune system. If some immune deficit is 
present some may concentrate at a particular site where they may lie dormant 
for years or even decades before causing disease.  
The most common sites of infection for extra-pulmonary TB in order of 
frequency are 
• Lymph glands  
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• Pleura (membrane than covers the lungs)  
• Genito-urinary tract. In women uterine disease is probably the most 
common while in men the epididymis is the site most frequently 
affected. Both sexes are affected by renal or bladder disease equally.  
• Bones and joints (also called osteotuberculosis)  
• Meninges which may be rapidly fatal if not, treated in time  
• Bowel and/or peritoneum  
• Pericardium (membrane around the heart)  
• Skin  
DISSEMINATED TUBERCULOSIS 
Disseminated TB, also referred to as miliary tuberculosis, is TB 
infection in several different organs simultaneously. Technically extra 
pulmonary TB is any TB infection outside the lungs, while miliary TB  It 
differs from EPTB that is a widespread infection outside the lungs. 
The symptoms of extra-pulmonary tuberculosis depend on the site(s) of 
infection.  In lymphadenitis, the lymph glands become swollen painful and 
may have a rubbery texture.  
Abscesses may form in the lymph glands and discharge onto the skin 
sinus  giving a very unsightly combination of swelling and pus around the 
neck.  
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Osteo-TB or TB in the bones and joints, causes pain and swelling of 
the affected part. Spinal disease may cause paraplegia if enough of the 
vertebrae are destroyed to cause instability of the spine.  
In tuberculous meningitis the symptoms usually begin gradually. 
Tuberculous meningitis may cause a wide variety of symptoms, including 
double vision and mental confusion developing over days or weeks. Patients 
may present with a headache that is either intermittent or persistent for 2-3 
weeks. If not detected and treated coma may develop. If treated soon enough 
recovery may be complete but long term complications (sequelae) are likely 
if the treatment is delayed.  
TB meningitis has the highest mortality of all complications of 
tuberculosis. Subtle mental status changes may progress to coma over a 
period of days to weeks. Fever may be low-grade or absent.  Abdominal 
disease characteristically causes pain and constipation. If advanced it may 
cause complete obstruction of the bowel.  Reported symptoms for genito-
urinary TB include; flank pain, painful urination, or urination frequency 
problems. In men, genital TB may present as epididymitis or a scrotal mass. 
In women, genital TB may mimic pelvic inflammatory disease.  
LABORTORY DIAGNOSIS  
This can be broadly divided into 
20 
 
1) Demonstration by Direct microscopy - light and Fluorescent 
2) Isolation of mycobacterium tuberculosis by culture 
3) Serodiagnosis of the infection 
4) Molecular methods 
 
DIRECT MICROSCOPY -STAINING 
i) ZIEHL-NEELSEN STAINING (ZN) 
ZN staining is a highly specific technique where AFB is demonstrated 
after staining. It is positive only if number of AFB is more 10000 per ml of 
specimen.  The correlation of positive smear to positive cultures may be only 
25% to 40%. 
 
ii) SPECIAL  STAINING FOR AFB 
FLUORESCENT MICROSCOPY   
Auramine dye is a fluorochrome, which can be raised to a higher 
energy level after absorbing Ultra violet (Excitation) light.  When the dye 
molecules return to their normal low energy state they release excess energy 
in the form of visible (fluorescent) light. Auramine requires blue excitation 
light, excitor filters that select light in 450-490 wavelength range and a 
barrier Fluorescent filter for 515.  Brightly fluorescent bacilli appear Yellow 
against a dark background.  Its sensitivity and specificity are fairly similar to 
ZN microscopy. 
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MYCOBACTERIAL CULTURE 
Definitive diagnosis depends on the bacteriological isolation and 
identification of Mycobacterium species from clinical specimens.   
SPECIMEN PREPARATION: 
HOMOGENIZATION: 
It is essential to release the mycobacteria from the body fluid or tissues 
in which they are embedded. Tissue requires mechanical homogenization 
before decontamination.  N-acetyl -L Cysteine (NALC) or 4% Sodium 
Hydroxide (NaOH) is used as a mucolytic agent to assist liquefaction of 
purulent samples . 
The high concentration of lipids in the cell wall of most mycobacteria 
makes them more resistant to killing by strong acid and alkaline solutions 
than other bacteria that may be present in the specimen.  Consequently, 
specimens likely to contain a mixed bacterial flora are treated with 
decontaminating agent to reduce the undesirable bacterial overgrowth and to 
liquefy the mucus. After treatment with the decontaminating agent for a 
carefully controlled time period, the acid or alkali used is neutralized and the 
mixture is centrifuged at high speed to concentrate the mycobacteria 
DIGESTION AND DECONTAMINATION: 
Various agents such as 4% sodium hydroxide, trisodium phosphate 
alone or in combination with benzalkonium chloride (Zepheran), N-Acetyl L 
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cysteine (NALC), cetyl pyridium chloride (CPC),4% oxalic acid and 5% 
sulphuric acid can be used. The exposure time to these decontaminating 
agents is very critical, as overexposure leads to loss of considerable number 
of mycobacteria. Each mycobacteriologist should select the agents to be 
employed in his laboratory on the basis of the number and types of specimens 
received. 
NEUTRALIZATION: 
After the decontamination time of 15-20 minutes usually, the agents is 
neutralized by the addition of distilled water or phosphate buffer, in case of 
decontamination with NALC. 
CENTRIFUGATION: 
Carefully controlled centrifugal force is important in the recovery of 
mycobacterium from clinical specimens.  This centrifugation is necessary to 
concentrate the bacilli. The sediment is inoculated into the media.  The 
recovery of culture is increased when the relative centrifugal force is around 
3000g for 15 minutes. 
INOCULATION OF SPECIMENS: 
Several egg based and agar based culture media are available for 
recovery of mycobacteria. Some of the non-selective media available are 
Lowenstein Jensen medium which is most commonly used in most of the 
clinical diagnostic laboratories, Petragnani medium, Middle brook 7H 10 
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agar and 7H 9 liquid medium. American Thoracic Society (ATS) medium, 
which contains less amount of malachite green, is recommended for use, for 
the usually sterile specimen such as CSF, pleural fluid, etc   
For extra pulmonary tuberculosis,  the specimen is inoculated  in the 
selective Kirchner synthetic liquid medium containing horse or bovine serum 
is  and  Lowenstein Jensen Medium and is incubated at 37 0 c . 10 -14 days is 
required for the growth in liquid medium and 3 to 6 weeks  for the Growth in 
solid medium .  It may yield high isolation from the paucibacillary samples. 
Subculture from the liquid medium on to the solid medium gives isolation of 
organism with distinct eugonic rough, tough and buff colonies.  About 4 to 8 
weeks is required for the growth. 
 
AUTOMATED DETECTION SYSTEMS: 
            Many Semi-automated and automated mycobacteria detection 
systems are currently available; they are the radiometric Bactec system, non-
radiometric MB/Bac T System and ESP Myco system.  Other manual 
systems are the mycobacterium Growth Indicator Tube (MGIT) system and 
Septi-chek System. 
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IDENTIFICATION TESTS 
These include Niacin production, Aryl sulphatase, Phosphatase, Catalase 
and Nitrate reductase activity. Classification of Mycobacterium into different 
species based on biochemical tests and growth characteristics have been 
described and evaluated by the International working group on Mycobacterial 
Taxonomy. The following basic tests are routinely employed to differentiate 
M. tuberculosis from other mycobacterial species. 
      IDENTIFICATION OF M. TUBERCULOSIS 
Test M. Tuberculosis Others  
Growth rate Slow Slow/rapid 
Temp. Requirement 35oC - 37oC 25oC – 37oC 
Pigmentation Absent Present/absent 
Niacin Positive Mostly negative 
Stability of catalase at 68oC Negative Positive 
Growth on PNB media Negative Positive 
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SPECIES LEVEL IDENTIFICATION OF NON-TUBERCULOUS 
MYCOBACTERIUM 
 
 
RUNYON’S CLASSIFICATION 
 
 Runyon        
Group   Growth Rate Pigmentation   Typical Member 
I Slow > = 5 day Photochromogenic (Yellow or                   orange Pigment after exposure to light) 
M. Kansasi 
M. marinum 
II Slow > 5 days Scotscochromogenic  (Yellow or orange pigment in the dark) M. scrofulaceum 
III Slow > 5 days Nonchromogenic No pigment in the dark or in the light 
M. avium 
M. intracellulare 
IV Rapid < 4 days Variable 
Fortuitum complex 
M. smegmatis 
M. phelei 
 
 
 
 
DRUG SUSCEPTIBILITY TESTS  
The three general methods are in use. 
 
THE ABSOLUTE CONCENTRATION METHOD: 
It involves standard inoculum on media containing graded 
concentration of drugs and resistance is expressed in terms of MIC - 
minimum inhibitory concentration. 
THE RESISTANCE RADIO METHOD:  
Compares the growth of known strain in the same set and test strain is 
various dilutions of drug media and resistance is expressed in terms of ratio 
of MIC of test strain / MIC of standard strain. 
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PROPORTION METHOD 
This method enables precise estimation of the proportion of bacilli, 
resistant to a given drug.  If >1% of strain show resistance compared to 
control at a critical concentration, the strain is considered as resistant. The 
proportion of bacilli resistant to a given drug is then determined by 
expressing the resistant portion as a percentage of the total population tested. 
LJ Slopes with different concentrations of various drugs are prepared 
and a standard inoculum giving approximately 10 CFU/ml is inoculated in to 
them and incubated at 37oC.  Cultures are examined for growth on 28th day. 
 
NONCONVENTIONAL AND NEW METHODS FOR DRUG 
SUSCEPTIBILITY TESTING 
  Drug susceptibility testing (DST) methods include the proportion 
method, the absolute concentration method, and the resistance ratio method. 
With the introduction of the BACTEC radiometric system, and its adaptation 
to perform DST of M. tuberculosis, these four methods were considered as 
the gold standard. The long turnaround time (TAT) and laboriousness of 
these methods stimulated the search for alternative and faster techniques. 
These new methods can be differentiated into genotypic and phenotypic 
methods.  
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GENOTYPICMETHODS 
These methods search for the genetic determinants of resistance rather than 
the resistance phenotype. In general, they have two basic steps: a molecular 
nucleic acid amplification step, such as PCR to amplify sections of the M. 
tuberculosis genome, known to be altered in resistant strains and a second 
step of assessing the amplified products for specific mutations correlating 
with resistance. These methods have several advantages: a faster TAT (days 
instead of weeks), no need for growth of the organism, the possibility for 
direct application to clinical specimens, reduction of biohazard risks, and 
feasibility for automation. Unfortunately, they also have disadvantages, 
including problems with inhibitors when applying these methods directly to 
clinical samples.  
DNA sequencing of PCR-amplified products has been the most widely 
used method, becoming the gold standard. It has been performed by both 
manual and automated procedures although the latter has been the most 
commonly used. It has been thoroughly used for characterizing mutations in 
the rpoB gene in rifampicin-resistant strains and to detect mutations 
responsible for resistance to other anti-TB drugs. Several other genotypic 
methods have been proposed to detect resistance to antibiotics, such as PCR-
single strand conformation polymorphism, PCR-heteroduplex formation, and 
solid-phase hybridization assays. Moreover, the Line Probe Assay (LiPA-Rif) 
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based on the hybridization of amplified DNA from cultured strains or clinical 
samples to ten probes encompassing the core region of the rpoB gene of M. 
tuberculosis, immobilized on a nitrocellulose strip, and the Genotype 
mycobacterium tuberculosis test (MTB) DR (Hain, Germany), a commercial 
system for the detection of the M. tuberculosis complex and its resistance to 
rifampicin and isoniazid from culture samples based on the detection of the 
most common mutations in the rpoB and katG genes, respectively. The LiPA-
Rif assay has been evaluated in different settings giving encouraging results.  
DNA microarrays and real-time PCR techniques have also been 
proposed as alternative methods for drug resistance detection; the former still 
beyond the reach of clinical diagnostic laboratories, and the latter being 
increasingly evaluated with promising results.  
PHENOTYPICMETHODS 
New phenotypic methods assess inhibition of M. tuberculosis in the 
presence of antibiotics by detecting earlier signs of growth using various 
technologies, for example, the measurement of metabolism with the aid of 
color indicators, or oxygen consumption, by early visualization of micro-
colonies, and by the use of phages.  
The MGIT system, in its manual or automated version and based on the 
measurement of oxygen consumption, has been thoroughly evaluated for DST 
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of M. tuberculosis to first- and second-line drugs showing a good 
concordance with the gold standard proportion method.  
The E-test, another commercial system (AB BIODISK, Solna, Sweden), 
based on strips with impregnated gradients of antibiotics for the 
determination of drug susceptibility allows the reading of minimal inhibitory 
concentrations directly on agar plates. Several studies have evaluated this test 
in comparison with the proportion method finding an agreement of >90 %. 
Two other commercial and automated methods for DST are the MB/BacT 
system (Organon Technika) and the ESP culture system II (Accumed 
International, Chicago, IL, USA). Both systems rely on heavy equipment and 
have also been evaluated in several studies.  
SEROLOGICAL DIAGNOSIS  
M. tuberculosis is the paradigm of the successful intracellular pathogen. 
Although the organism evokes both a humoral and a cellular immune 
response, it is the later that determines the outcome of an infection. A variety 
of immunodiagnostic tests for tuberculosis based on the recognition of 
specific host response to the infecting organism have been described. The 
first test was the tuberculin skin test.   The short comings of this test include 
the inability to distinguish active disease from past sensitization and 
unknown predictive values .  There has been development of serological tests 
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for tuberculosis, but no test has found widespread clinical use, because of low 
specificity. 
Sensitivity and specificity increase if ELISA with purified antigen is done. 
The antigens tested in serological assays include the 38 KDa antigen, 
Lipoarabinomannan, Antigen-60,  antigen 85 KDa complex and glycolipids 
including phenolic glycolipid Tb1, 2y3 – diacyl trehalose and lipo-
oligosaccharide. 
Most patients with tuberculosis produce antibody to glycolipids and 38 
KDa and 85 complex antigens and most healthy controls do not.  However, a 
small proportion of tuberculous patients still have low levels or an absence of 
antibodies against any of these antigens. 
A number of antigen capture assays based on enzyme-linked I
 mmunosorbant assay, western blot analysis of M. tuberculosis H37RV 
culture filtrates antigen, radio immunoassay or agglutination of antibody 
coated latex particles have been described.  There is wide variation in 
sensitivity and specificity of these tests and the antigen test cannot be 
recommended at this time. 
 
MOLECULAR DIAGNOSIS 
In recent times, polymerase chain reaction (PCR) has been found to be the 
most sensitive technique for rapid diagnosis of M. tuberculosis.  This 
technique, capable of amplifying minute amounts of a specific DNA 
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sequence into millions of identical copies has revolutionalised molecular 
biology research. 
PCR is accomplished in the following manner. A specimen that may 
contain the organism with the DNA sequence of interest is heated to 
denature the double stranded DNA.  The specific synthetic oligonucleotide  
‘Primers’ (short single stranded pieces of DNA) bind to the unique DNA 
sequences of interest and a heat stable DNA polymerase extends the primers 
to create a complete and complementary strand of DNA. This process is 
typically repeated sequentially 20-40 times, thereby creating million of 
copies of target DNA sequence. The amplified sequences can then be 
detected easily by gel elecrophoresis. 
The IS 6110 belongs to a class of molecules known as transposons, 
which are self-replicating stretches of DNA.   This sequence has been found 
in the M. tuberculosis complex of organism (M. Tuberculosis, M. africanum, 
M. microti and M. bovis) but in no other mycobacterial species.  Thus 
IS6110 serves as a useful amplification target in diagnosing tuberculosis 
because except for M. tuberculosis the members of the M. tuberculosis 
complex are not the usual human pathogens or colonizers.   
Other amplification targets for PCR are possible. A popular choice in 
molecular diagnostics has been to use the ribosomal RNA (r RNA) sequence 
as amplification target, as these sequences are found in abundance in living 
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organism and should allow even more sensitive PCR - based assay. 
Ribosomal RNA is highly specific and abundant for any particular species. 
The Restricted Fragment Length Polymorphism (RFLP) technique using 
the IS6110 repetitive sequence is considered for typing the M.tuberculosis 
complex strains. It involves the extraction of genomic DNA, restriction 
endonuclease digestion with PvoII, Southern blotting and probing for 
IS6110. Standardization of the procedure facilitates inter-laboratory 
comparability of patterns.  However comparison of profiles requires 
sophisticated software for image analysis and well-trained technical staff.  
Other molecular methods such as spoligotyping and whole genome finger- 
typing methods used for epidemiological studies.  Other recent methods 
include phage-based assays (Commercial kits-FAST Plague-TB), which 
diagnosis TB directly from specimens.  Newer Versions are also being 
developed for the detection of drug resistance directly from sputum 
specimens. 
 
 
 
OTHER METHODS FOR RAPID IDENTIFICATION:  
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY: 
Each species of mycobacterium appears to synthesize a unique set of 
mycolic acid.  Qualitative and quantitative differences in the spectrum of 
mycolic acids present in the cell wall are reliable criteria to identify 
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mycobacterial species.  Once mycobacterial cultures are available, the 
mycolic acids are extracted from saponified mycobacterium, converted to b -
bromophenacyl esters and analyzed by higher performance liquid 
chromatography (HPLC).  The resulting pattern is compared to a library of 
referring patterns to identify the species. This assay can provide rapid 
definite species identification for essentially any mycobacterium isolate in 
contrast to the time-consuming biochemical procedures and other 
conventional tests for speciation.  
 
IMPLEMENTATION AND PERSPECTIVES FOR NEW 
DIAGNOSTIC METHODS                 
Concerning serological approaches for the diagnosis of TB, none of the 
several tests proposed until now using a variety of mycobacterial antigens 
have shown to be predictive enough to warrant their routine use as a 
diagnostic test for TB. Apparently, tests using a cocktail of antigens, rather 
than a single more specific antigen, have given better results. The new 
ELISA-based tests like the QuantiFERON-TB test and the T SPOT-TB 
assay, which measure the production of IFN-by activated T cells, are 
promising; however, more studies are needed in different settings to assess 
their usefulness as a diagnostic tool in certain populations, such as those 
subjects immune suppressed by HIV infection or other diseases, and in 
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children. The cost of these tests, since they are also available as a 
commercial kit, will have an impact on the feasibility for their 
implementation on a routine basis in the future.     
The phage-based tests have also been evaluated in different settings 
either as a commercial kit or as the in-house method. The low sensitivity 
obtained in some of these studies could have been due to low infectivity of 
the phages, which also can be affected by the age and condition of the 
samples. In contrast, in the studies where the phage-based methods have 
shown an increased sensitivity as compared with direct microscopy and 
culture, the volume of sample used was up to five-times higher than that used 
for culture. It seems that, in their current format, the phage-based assays are 
not ready as a tool to improve diagnosis of TB. However, they seem to be 
appropriate for rapid rifampicin resistance detection.  
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MATERIALS AND METHODS 
 
 
STUDY POPULATION 
 
  A total of 110 patients clinically diagnosed as Extra Pulmonary 
Tuberculosis attending as out-patient and as well as In-patient in Stanley 
Medical College and Hospital, Chennai were included in the study. 
 
STUDY PERIOD 
June 2009 to June 2010 
 
PLACE OF STUDY 
Stanley Medical Hospital and college Chennai 
 
SPECIMENS 
1. Cerebrospinal 
2. Pleural Fluid 
3. Ascitic Fluid 
4. Pus  
5. Urine 
 
THE METHODOLOGY INCLUDED 
 
• Collection of specimen. 
• Specimen processing 
• Identification of the pathogens 
• Drug susceptibility tests 
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• Molecular Method for detection of Mycobacterium tuberculosis by 
polymerase Chain reaction from clinical specimens. 
 
INCLUSION CRITERIA  
 
 All patients with suspected extra pulmonary tuberculosis were screened 
based on their clinical history and symptoms. 
 
1. Age greater or equal to 18 years 
2. Weight loss of at least 10% of healthy body weight. 
3. One focal symptom lasting for two weeks or more 45,44,22,27,16,47. 
 
 
EXTRA PULMONARY TB 
 
Tuberculosis meningitis 
(TBM) 
Fever,Headache,Vomiting 
and alteration of sensorium 
   Pleural Tuberculosis 
 
Fever ,dyspnea and Chest 
pain 
  Tuberculosis Peritonitis Fever, ascitis and 
abdominal pain 
Renal Tuberculosis Flankpain, 
dysuria,hematuria and 
pyuria 
Cold abscess Fever, painless slowly 
progressive swelling,  
cervical lymphadenitis  
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EXCLUSION CRITERIA  
 
1. Age below 18 years  
2. Received Anti TB treatment within last 6 months. 
 
 
SAMPLE COLLECTION 
 
 
1. BODY FLUIDS  
 
 Cerebrospinal Fluid was collected by lumbar puncture. Pleural Fluid 
and Ascitic Fluid were collected in universal sterile container by 
aspiration aseptically. The larger specimen volumes were collected to 
increase culture yields. 
Cerebrospinal Fluid   -  3 – 5 ml  
Pleural Fluid   -  10 ml 
Ascitic Fluid   - 10 ml  
 
2. URINE SAMPLE 
 
The first morning whole urine was collected on three consecutive days 
in sterile container.  
 
3. PUS SAMPLE 
 
Pus sample was aspirated from cold abscess in the cervical region 
using disposable syringe aseptically.   
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PREPARATION OF SMEARS: 58 
 
  With the 5mm internal diameter24SWG nichrome wire, the specimen 
was taken     and  3 X 2 cm  wide  smear was made  in the center of the slide. 
Slides were air-dried and heat fixed   in the safety cabinet (Class 1)58. 
 
 FLUORESCENCE STAINING (AURAMINE PHENOL):8 
 
• The slide was covered with freshly filtered auramine phenol for 10mts. 
• Washed well with running tap water in a controlled flow. 
• Decolourisation was done by covering completely with acid alcohol for 
2mts. 
• Washed again with running tap water. 
• Counter stained with 0.1% potassium permanganate for 30 seconds. 
• Washed again with water and was placed in a hot plate to dry. 
• Examined the stained smear under the high power objective of the 
fluorescence microscope. 
 
 FLUORESCENCE MICROSCOPY:  
 
 The mercury vapour lamp was switched on 10 minutes before 
examining. Using the low power (magnification=x150) objective first 
examine a known positive slide to ensure that the microscope is correctly set 
up. Morphology of the bacilli was identified and was graded using the high 
power objective. With auramine staining, the bacilli appear as slunder with 
bright yellow fluorescent rods, standing out clearly against a dark 
background. A smear is positive it contains a minimum of 4 AFB of typical 
morphology in the entire smear. If less than 4 bacilli are present, report as 
negative, However, the number of bacilli, if less than four, is noted in the 
smear record book. For positive smears at least 50 fields have to be screened. 
Report the smear as negative if no AFB was seen in the entire smear. 
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No of acid-fast bacilli (AFB) 
per HPF 
Report 
 
No AFB-  Entire Smear 
Negative 
 
< 6 bacilli per field 
 
1+ 
6-100 bacilli per field 
 
2+ 
> 100 bacilli per field or large 
clumps 
3+ 
 
 
 
MODIFIED ZIEHL-NEELSEN STAINING PROCEDURE: 29 
 
 1. The smear was dried and heat fixed. 
 2. The entire slide was flooded with strong carbol-fuchsin. 
 3 Intermittent heating was done  until fumes arise for 5 minutes. 
4. The slide was rinsed in a gentle stream of running water until all free 
stain is washed away. 
 5. The slide was flooded with acid alcohol (3%) as a decolorizing 
agent for 2 to 3 minutes. 
6. Rinsed the slide thoroughly with water and drained the excess water 
from the slide. 
7. Flooded the slides with (0.1%)   methylene blue counter stain for 30 
seconds. 
8. Rinsed the slide thoroughly with water and allowed the smear to air 
dry. 
            9.Examined the stained smear under oil  immersion  microscope 
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RECORDING AND REPORTING OF RESULTS: 20 
 
 Ziehl-Neelsen’s stained smears, were interpreted according to Tuberculosis 
research centre guidelines 
 
No of acid-fast bacilli (AFB) Report 
No AFB/ 100  oil immersion fields Negative 
1-9 AFB/200 oil  immersion fields 1-9 AFB per 200 fields 
10-99 AFB/ 100 oil immersion fields 1+ 
1-10 AFB/ 50 oil immersion fields 2+ 
More than 10 AFB/ 20 oil immersion  
fields 3+ 
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Culture Methods 3,33 
 
CEREBROSPINAL / PLEURAL FLUID PROCESSING 
 
 
 
 
 
 
 
                                                                  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Lowenstein _ Jensen Medium 
## Lowenstien – Jensen Medium with sodium pyruvate 
### Kirchner”s Synthetic Medium 
 
                                
CEREBROSPINAL / PLEURAL FLUID 
               Direct inoculation            Decontamination 
After direct inoculation, centrifuge remaining CSF at 3000 g for 15 
minutes 
Decant supernatant carefully 
To deposit add 1 ml sterile distilled water
Add 1 ml 5 % H2so4
Mix well and let stand for 15 minutes 
Fill up bottle with sterile distilled water 
          Centrifuge at 3000 g for 15 minutes .Discard 
Inoculate one loopful onto one slope each  L J#  and L J P##  
Transfer remaining deposit into one bottle of SK##.Label this 
set as B and incubate at 37o C 
 
Inoculate one looful CSF onto one slope each of L J#  and L 
J P## Then add 0.2 ml of CSF into one bottle of SK###  
medium .Label these as set ‘A’ Incubate at 37o C  
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URINE /ASCITIC FLUID  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DSS - Decontaminated specimen Supernatant 
DSD – Decontaminated specimen deposit  # Lowenstien – Jensen Medium 
## Lowenstien – Jensen Medium 
with                sodium pyruvate 
## Kirchner’s Synthetic Medium 
 
                                
Distribute entire specimen in 20ml volumes into sterile universal 
containers and centrifuge at 3000 g for 15 minutes 
Deposit Supernatant 
Pool all deposit in a 
single container 
Transfer 1ml each of top 
layer into 3-4 bottles 
  
Process by H2SO4 To each bottle add 1ml of 5% 
H2SO4 sterile distilled water 
  
Inoculate 2 bottles 
each of L J#, L J –
P## and SK###    
media 
Mix and allow to stand for 15 
minutes  
Fill up bottle with distilled 
water and centrifuge method 
Deposit Supernatant 
Add to SK medium 
(maximum 2 
bottles) 
Transfer 1 ml from 
each bottle into SK 
medium (maximum 
2 bottles 
Label as ‘DSD’ and 
incubate at 37 o C 
Label as ‘DSS’ and 
incubate at 37 o C 
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SAMPLE PROCESSING FOR PUS SAMPLES: 35 
 
 The pus sample was homogenized in Vortex for few minutes to free bacilli from 
the mucus, cells or tissue in which they may be embedded. Decontamination was done by 
sodium hydroxide (modified Petroff) method.  
 
 
 
 
 
 
 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Lowenstein _ Jensen Medium 
## Lowenstien – Jensen Medium with  sodium pyruvate 
### Kirchner”s Synthetic Medium 
 
 
 
 
 
 
 
 
 
Sediment was resuspended with 20 ml sterile distilled water  
Centrifuged at 3000 g for 15 minutes
10 ml of 4% NaOH was added to 5ml of pus 
Allowed to stand for 15 mins at room temperature with occasional shaking 
Poured off supernatant
Centrifuged at 3000g for 15 minutes
Decanted supernatant and sediment was inoculated on to 2 slopes of LJ Medium # and 2 
slopes of L J-P## and SK Medium ###    incubate at 37 o C 
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PROCESSING OF SPECIMEN FROM LIQUID MEDIUM TO SOLID MEDIUM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
# Lowenstein _ Jensen Medium 
## Lowenstien – Jensen Medium with  sodium pyruvate 
### Kirchner”s Synthetic Medium 
 
 
 
 
PURPOSE OF CULTURE  
 
  Compared to other bacteria, which typically reproduce within minutes, 
M.tuberculosis proliferates extremely slowly (generation time 18-24 hours). 
Hence the cultures, which have been incubated at 37C for at least 9 days, are 
examined each Monday for 8 consecutive weeks or until they become 
positive or contaminated. 
 
PRINCIPLE OF CULTURE 
Tubercle bacilli do not grow in primary culture in less than one week and 
usually require two to four weeks to give visible growth from sputum 
specimens. Typical colonies of M.tuberculosis are rough, crumbly, waxy, 
Sediment was inoculated into 2 slopes of SK 
Medium ## 
 
Incubated 35 o C – 37 o C 
 
 
Turbidity was noted 
 
 
                 Decontamination was done  
 
 
Decontaminated specimen was Inoculated into 2 
slopes of L J# , L J-P### and S K## medium and 
incubate at 37 o C 
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non-pigmented(buff colored) and slow-growers having the appearance of 
breadcrumbs or cauliflower. 
 
 
 CULTURE EXAMINATION AND IDENTIFICATION 
 
 All cultures examined 48 to 72 hours after inoculation to detect gross 
contamination. The cultures were examined weekly up to 8 weeks.  
 
CULTURE REPORTS 
 
 Cultures were recorded qualitatively (growth positive or negative) as 
well as quantitatively (number of colonies isolated). The following scheme 
was recommended. 
 
Reading Report 
No growth Negative 
1-19 colonies Positive (number of colonies) 
20-100 colonies Positive (1+) 
More than 100 discrete colonies  Positive (2+) 
Confluent growth Positive (3+) 
Contaminated Contaminated 
 
IDENTIFICATION TESTS 
Culture positives were identified based on the following test. 
 
1.  Susceptibility to p-nitro benzoic acid (PNB) 
2. Niacin test 
3. Catalase activity at 68oC/pH 7 
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1.  Susceptibility to p-nitro benzoic acid (PNB) 
The neat bacterial suspension was inoculated into 2 slopes of LJ 
medium without drugs and 1 slope of LJ medium containing 500mg/liter of  
PNB  and incubated at 37oC. Reading was taken after 28 days. 
 
Interpretation 
  M.tuberculosis does not grow on PNB medium. 
 
2. Niacin test 
Reagents 
1. 1.5% Ortho -toludine  
2. 10%  Cyanogen bromide solution  
 
LJ bottles with culture were Autoclaved at 121oC for 20 minutes 
 
Bottles were placed upright for 20-30 minutes to cool and the fluid was 
allowed to drain to bottom 
 
Pipette out 0.25ml of the autoclaved culture extract into a clean screw-capped 
tube 
 
0.25ml of Ortho -toludine (1.5%) and 0.25ml of 10% cyanogen bromide 
solution was added sequentially to the culture tube. 
 
Pink color was observed within 5 minutes(+ve). 
 
Sufficient 4% NaOH solution was added to discard tubes for neutralization 
the cyanogen bromide. 
 
 
 
Positive control: Extract from culture of M.tuberculosis H37 RV. 
Negative control: Extract from uninoculated tube of medium. 
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3.Catalse Test at 68oC /pH7.0 
 
REAGENTS 
1. 0.067M phosphate buffer solution, pH7.0 
A. Na2HPO4 anhydrous  9.47g 
Distilled Water    1 litre 
Dissolved disodium phosphate in water to provide 0.067M solution 
(Solution1) 
B. KH2PO4    9.07g 
Distilled water    1 litre 
Dissolved in water to give 0.067 M KH2PO4 solutions (Solution B) 
Mixed 61.1ml of Solution A with 38.9ml of Solution2. 
2. 30% hydrogen peroxide solution 
3. 10% Tween-80  
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PROCEDURE 
 
 
 
With a sterile pipette, aseptically added 0.5ml of 0.067 M buffer into 16 X 
125 mm screw-capped test tubes 
 
Loopful of the culture was suspended in the buffer solution, using a sterile 
loop 
 
 
Tubes with the emulsified culture were placed in a previously heated water 
bath at 68oC for 20 minutes. 
 
Tubes were removed from heat and cooled to room temperature 
 
Add 0.5ml of 10% tween 80 and 0.5ml of 30% hydrogen  
 
Formation of bubbles appearing on the surface of the liquid was observed. 
Tubes should not be shaken because Tween-80 may also form bubbles when 
shaken, resulting in false positives. 
 
Test tubes were kept for 20 minutes before discarding 
 
 
Use a slope of M.tuberculosis as a negative control and M.terrae complex 
as a positive control. 
 
 
 
INTERPRETATION 
 
 M.tuberculosis showed catalse negative at 68oC. 
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SPECIES LEVEL IDENTIFICATION OF NON-TUBERCULOUS 
MYCOBACTERIUM : 
 
 Mycobacterium fortuitum was identified by 
 growth on Mac Conkey Agar, 
 positive reaction for nitrate reduction,  
 growth on L-J medium with 5% sodium chloride   
 positive semi quantitative catalase test. 
 Iron uptake positive. 
 Sensitivity to ciprofloxacin. 
 
 Mycobacterium chelonei was identified by 
o growth on Mac Conkey agar  
o negative reaction for nitrate reduction. 
o growth on L-J medium with 5% sodium chloride. 
o negative semi quantitative catalase test  
o Iron Uptake negative. 
o Sensitive  to polymyxin 
 
 
 
DETERMINING DRUG SUSCEPTIBILITY OF MYCOBACTERIUM 
TUBERCULOSIS BY PROPORTION METHOD 55 
 
PREPARATION OF MCFARLAND NEPHELOMETER BARIUM CHLORIDE 
STANDARDS (PAIK, G.1980) 
 
a) Prepared 1% aqueous barium chloride (100mg of barium chloride 
(anhydrous) in 10 ml of sterile distilled water (SDW). 
b) Prepared 10 ml of 1% sulphuric acid solution (99 ml of distilled water 
and 1 ml of concentrated sulphuric acid). 
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c) Added 0.1 ml of 1% Barium Chloride solution to 9.9 ml of 1% 
Sulphuric acid solution to obtain the McFarland standard, which 
matched with 1 mg/ ml of M. tuberculosis 
d) Sealed the tubes ( Wrap with Para film) and labeled as No. 1 
McFarland standard tube with date of preparation 
e) Used Wire meshes to hold McCartney bottles and bijou bottles 
 
INOCULUM PREPARATION 
 
1. With a 3 mm wire loop, a representative sample of approximately 4-5 
mg (loop full) was taken from the primary culture and placed on the 
side wall of a McCartney bottle containing  1 ml SDW and 6 glass 
beads of diameter 3 mm 
2. The bacterial inoculation was emulsified, (with a loop of water, if 
required), on to the side wall of McCartney bottle in round rotary 
movements with inoculation loop, till the bacterial mass was 
emulsified, (this was variable by reduction in the clumpy hydrophobic 
to aqueous hydrophilic nature of suspension) 
3. The suspension was emulsified by fully dissolving in the 1 ml of sterile 
distilled water (SDW) 
4. Vortex the bottle for 20-30 seconds 
5. 4 ml of distilled water was added slowly 
6. The coarse particles were allowed to settle down (leave it on stand for 
approximately 5 min) 
7. The Mycobacterium solution was decanted carefully into another clear, 
sterile McCartney bottle 
8. The turbidity of inoculums was matched with McFarland standard 
no.1, against a black background.   This was the neat bacterial 
suspension standardized as 1 mg/ml, equaling to 107 to 108 CFU/ml.   
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9. If required, the opacity of the bacterial suspension was then adjusted 
by the addition of distilled water to obtain a concentration of 1 mg/ml 
of tubercle bacilli by matching with McFarland’s standard  
10. Make further two log dilutions  were  made to achieve 10-2 and 10-4 
dilutions as given below 
 
a. The dilution 10-2 was produced by discharging two loop full of 
the neat bacterial suspension, into a small tube containing 2 ml 
of distilled water, and shaking 
b. Similarly the dilution 10-4 was produced by discharging two loop 
full of the dilution 10-2 into a small tube containing 2 ml of 
distilled water, and shaking   
Neat:     1 ml SDW with six 3 mm glass beads + 1 loop-full (3mm     
                 Loop)  of culture 
 
 
   
       Vortex for 20 – 30 seconds 
 
   
       Add 4 ml of SDW to the above 
 
 
      Adjusted turbidity with McFarland std.1 with SDW 
 
 
S2-10-2            Two loop-full of neat + 2 ml of SDW, vortex 
S2-10-4             
 
                         Two loop –full of s2 + 2 ml of SDW 
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Preparation of Lowenstein-Jensen (LJ) Medium with anti-TB 
drugs (Streptomycin,  Isoniazid,  Rifampicin and 
Ethambutol)  
 
  
All strains of tuberculosis contain some subpopulation of bacilli that 
are resistant to antiTB drugs.  However, in resistant strains, the proportion of 
such bacilli is considerably higher than the sensitive strains.  The proportion 
method calculates the proportion of resistant bacilli present in a strain.  Two 
appropriate dilution of the bacilli, 10-2 and 10-4 dilutions (undiluted = 106 to 
108 CFU/ml), were inoculated on drug-containing and drug-free media, in 
order to obtain countable colonies on both media. Numbers of colonies were 
observed on the drug-containing media to drug-free medium indicates 
proportion of resistant bacilli present in the strain.  Below a certain 
proportion (critical proportion = 1%), the strain was classified as sensitive 
and above, as resistant. 
 
           No of colonies appearing on drug containing medium 
-----------------------------------------------------------------------
 * 100 
No of colonies appearing on drug free medium 
< 1%  Sensitive to the drugs. 
>1% Resistance to the drugs. 
 
One set of media bottles for testing one culture consist of five LJ slope, 
one for neat, two for 10-2 and two for 10-4 ; eight LJ drug containing slopes, 
two each for drugs H, R, E & S (One each for 10-2 and 10-4 suspensions) and 
one for p-nitro benzoic acid slope, were required. 
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H  ISONIAZID  
R  RIFAMPICIN 
E  ETHAMBUTOL 
S  STREPTOMYCIN 
 
 
Incubation and Reading 
Incubated the inoculated slopes at 37⁰C.  Reading of the growth was 
taken at 28 days and again at 42 days. 
Recorded the growth as Confluent growth = 3 +;  
More than 100 colonies = 2 +; 
Record actual number of colonies = 1 – 100 cols. 
When the number of colonies on a given dilution was less than 5, counted the 
number of colonies with the next larger inoculums, or estimated if more than 
100.  
 
INTERPRETATION OF THE TEST 
 
First reading was taken at 28th day after inoculation. 
1. Counted the colonies only on the slopes seeded with the 
inoculums that has produced exact readable counts or actual 
counts (up to 100 colonies on the slope).  This inoculums may 
be the same for the control slopes and the drug-containing 
slopes, or it may be the low inoculums (10-4 dilution) for the 
control slopes and the high inoculums (10-2 dilution) for the 
drug-containing slopes 
2. The average number of colonies obtained for the drug-
containing slopes indicated the number of resistant bacilli 
contained in the inoculums. 
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3. Dividing the number of colonies in drug containing slopes by 
that in drug free slopes gave the proportion of resistant bacilli 
existing in the strain.  Below a certain value the critical 
proportion – the strain was classified as sensitive; above that 
value, it was classified as resistant.  The proportions were 
reported as percentages. 
4. If according to the criteria indicated below, the result of the 
reading was made on the 28th day was “resistant”, no further 
reading of the test for that drug was required:  the stain was 
classified as resistant.  If the result at the 28th day was 
“sensitive” a second reading was made on the 42nd day only for 
the sensitive strain.  The final definitive results for all four drugs 
on 28th day, then the report was given on the same day.  
Otherwise, incomplete reports should be given before 42nd day. 
 
 
 
 
DEFINITION OF RESISTANCE 
 
Drug Level of Resistance 
Streptomycin Resistance ratio of drug conc. 8 μ g/ml or more were 
resistant 
Isoniazid MIC of drug conc. 5 μ g/ml or more were resistant 
Rifampicin MIC of drug conc. 128 μ g/ml or more can be tentatively 
interpreted as resistant 
Ethambutol MIC of 8 drug conc. 8 μ g/ml or more can be tentatively 
interpreted as resistant 
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MOLECULAR METHOD FOR DETECTION OF TUBERCULOSIS BY 
POLYMERASE CHAIN REACTION 10,14,12 
 
Extraction of DNA from clinical samples  
 
DNAzol Direct is a universal reagent for processing biological samples 
for direct PCR. No isolation of DNA is required. The DNAzol Direct 
procedure is simple; lyse a sample in DNAzol Direct for 15 minutes, add an 
aliquot of the resulting lysate to a PCR mix and perform amplification of a 
selected DNA fragment(s). The standard DNAzol Direct procedure supports 
PCR amplification of DNA fragments up to 8 kb long. 
 
The combined effects of the alkaline pH and chaoptropic properties of 
DNAzol Direct sufficiently inactivate PCR inhibitors including proteases and 
nucleic acid degradation enzymes. After processing a sample in DNAzol 
Direct, DNA is denatured into a single-stranded form, RNA is hydrolyzed, 
and proteins are denatured and partially hydrolyzed. Due to its unique 
composition, the DNAzol Direct lysate does not require neutralization before 
its use in PCR. The resulting pH of a PCR mix containing less than 10% of 
the lysate is within the effective range for PCR. 
 
PROTOCOL 
 
1. Mixed 10 µl of fluid sample with 0.1 ml(100 µl) of DNAzol Direct. 
2. Lysed the sample by incubation in DNAzol Direct for 15-20 minutes at 
room temperature. 
3. Vortexed the lysate and transferred a 3 µl aliquot directly into 22 µl of 
PCR mix. 
PCR MIX3 
1. 15 µl master mix 
2. 1 µl forward primer 
3. 1 µl reverse primer 
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4. 5 µl double distilled water 
5. 3 µl DNA template 
 
PCR AMPLIFICATION AND DOCUMENTATION 
 
Amplification of DNA was performed with primers IS-F-5’-
CCTGCGAGCGTAGGCGTCGG-3.and IS-R-
5’CTCGTCCAGCGCCGCTTCGG-3., to amplify 123 bp fragment of 
insertion element IS6110 of M. tuberculosis complex as reported earlier,2 . 
Amplifications was done. Conditions followed were initial denaturation at 
94°C for four minutes, followed by 35 cycles at 90°C for one minute, 60°C 
for one minute, and 72°C for one minute, and a final extension at 72°C for 10 
minutes. The amplified products were subjected to electrophoresis on a 2% 
agrose gel containing ethidium bromide and the results were documented. 
Throughout the PCR processing the three room procedure and other 
recommended stringent precautions were followed and the results were 
evaluated in the light of the performance of appropriate positive and negative 
controls, to avoid cross-contamination and false positive reactions. 
Component Vol./reaction Final Conc., 
Taq Master Mix RED 25 µL 1X 
Primer A Variable 0.1-1.0 µM 
Primer B Variable 0.1-1.0 µM 
Distilled Water Variable ------- 
Template DNA Variable Variable 
TOTAL volume 50 µL ------- 
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PREPARATION OF AGAROSE GEL 
 
¾ To prepare 2% agarose gel 400 grams agarose powder was mixed 
with 35 ml of electrophoresis buffer, heated in a microwave oven, 
mixed well until the agarose was uniformly dissolved. 
¾ After cooling to about 60 °C, 10 micro litre of ethidiumbromide 
was added to the gel (final concentration 0.5 ug\ ml) to facilitate 
visualization of DNA after electrophoresis.  
¾ After cooling the solution, it is poured into casting tray 
containing a sample comb and allowed to solidify at room 
temperature.  
¾ After the gel hardness enough, the gel was mounted in 
electrophoresis tank.  
¾ Electrophoresis buffer is poured into the electrophoresis tank so 
that the gel was completely immersed.  
¾ The comb carefully removed .  
¾ Ethidium Bromide is mutagenic and should be handled with 
extreme caution. 
 
 
GEL ELECTROPHORESIS  
 
¾ Electrical leads were connected. As the DNA amplified by PCR 
was charged negative, it migrates from cathode to anode.   
¾ The mixture was slowly loaded into the slots of the submerged 
gel using a micropipette. 
¾ Marker DNAs of known size was loaded into slots. Constant 
voltage of 50 -150 V was applied to allow the gel run until the 
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Taq DNA Polymerase Master Mix Red  have migrated ¾ the 
length of the gel .  
¾ All PCR products were analyzed in 2% agarose gel, stained with 
ethidium bromide and observed under UV transilluminator. 
 
RESULT  
The IS 6110 of Mycobacterium tuberculosis was amplified at 123 base pair. 
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RESULT 
 
A total number of 125 clinically diagnosed EPTB patients based on 
symptoms and history were included in the study. The period of study was 
one year June 2009–2010. Specimens were collected from outpatients as well 
as inpatients of Government, Stanley Medical College and Hospital, Chennai. 
Among the  125 EPTB cases, 48 were Cerebrospinal fluid, 44 were pleural 
fluids, 15 were Ascitic fluids, 10 were Pus and 8 were Urine samples.  
 
Samples were subject to standard bacteriological diagnosis by smear 
study (florescence staining & Ziehl –Neelson staining), culture examination 
by using solid Lowenstein-Jensen medium & Liquid Kirchner’s medium and 
molecular method  for  detection of DNA of mycobacterium Tuberculosis by 
polymerase chain reaction using IS6110. Drug susceptibility testing done  by 
proportion method .  
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TABLE 1 
AGE DISTRIBUTION OF THE SPECIMEN CASES (N = 125) 
 
SNo Age Male Female Total % 
1 18-30 29 16 45 36 
2 31-40 23 17 40 32 
3 41-50 17 5 22 17.6 
4 52-60 10 1 11 8.8 
5 61-70 7 0 7 5.6 
TOTAL 86 39 125 100.00 
The average age group in the study was 36.64. 
TABLE 2 
GENDER DISTRIBUTION OF THE CASES (N = 125) 
S.No Sex Numbers 
Percentage 
(%) 
1 Male 86 68.8 
2 Female 39 31.2 
  125 
100 
 
The study group showed male predominance (68.8%). 
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TABLE 3 
TYPE OF SPECIMENS (N = 125) 
 
S. No. Type of Specimens
No of 
Specimens 
Percentage 
% 
1 Cerebrospinal fluid 48 38.40 
2 Pleural fluid 44 35.20 
3 Ascitic fluid 15 12.00 
4 Pus 10 8.00 
5 Urine 8 6.40 
Total 125 100 
 
Out of 125 samples, cerebrospinal fluids (48) and Pleural fluids (44) 
were predominant.  The other fluids collected were Ascitic fluid (15), Pus 
(10) and Urine (8). 
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TABLE 4 
SMEAR POSITIVES BY ZIEHL- NEELSEN STAINING (N = 125) 
S.No Types of samples 
No of 
samples 
Smear 
ZN % 
1 Cerebrospinal fluid 48 3 6.25 
2 Pleural fluid 44 2 4.55 
3 Ascitic fluid 15 1 6.67 
4 Pus 10 2 20.00 
5 Urine 8 2 25.00 
 
Total 125 10 8.00 
 
 
By Zeihl- Neelsen staining smear positives in Cerebrospinal fluid 
samples were three. In the Pleural fluid, Pus & Urine samples it was two and 
one in  Ascitic fluid samples. 
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TABLE 5 
SMEAR POSITIVES BY FLUORESCENCE STAINING (N = 125) 
S.No Types of samples
No of 
samples 
Smear 
FM % 
1 
Cerebrospinal 
fluid 
48 4 8.33 
2 Pleural fluid 44 3 6.82 
3 Ascitic fluid 15 2 13.33 
4 Pus 10 3 30.00 
5 Urine 8 2 25.00 
 
Total 125 14 11.20 
 
 
Out of 48 Cerebrospinal fluid samples the smear positives by 
fluorescence staining were four. There were three positives in the Pleural 
fluids and Pus samples. Two smear positives were detected in Ascitic fluid 
and Urine samples. 
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TABLE 6 
COMPARISON OF ZIEHL NEELSEN AND FLUORESCENCE 
STAINING 
S. No 
Types of 
samples 
No of 
samples 
Smear 
ZN % FM % 
1 
Cerebrospinal 
fluid 
48 3 6.25 4 8.33 
2 Pleural fluid 44 2 4.54 3 6.82 
3 Ascitic fluid 15 1 6.66 2 13.33 
4 Pus 10 2 20.00 3 30.00 
5 Urine 8 2 25.00 2 25.00 
 
Total 125 10 8.00 14 11.20 
  
 
Out of 125 samples, smear positives by   Ziehl –Neelsen staining was 
found to be 10 and by fluorescence staining was 14. The percentage of smear 
positives by fluorescence staining was found to be greater than the Ziehl –
Neelsen staining.                
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TABLE 7 
Comparison of culture positive By KIRCHNER’S , LOWENSTEIN-
JENSEN medium and LOWENSTEIN JENSEN with sodium pyruvate –
p (n = 125) 
 
S.
N
o 
Types of 
samples 
No.of 
sample
s 
LJ 
Mediu
m 
LJ With 
Sodium 
Pyruvate 
(LJ-P) 
Time 
taken 
For 
Growth
Kirchner
s 
Medium 
Time 
Taken 
For 
Growth
 
1 
Cerebro 
Spinal 
Fluid 
48 6 No Growth 
3-4 
wks 
6 
10-16 
days 
2 
Pleural 
Fluid 
44 4 
No Growth 
- 
3-4 
wks 
4 
10-16 
days 
3 
Ascitic 
Fluid 
15 4 No Growth 
3-5 
wks 
4 
10-16 
days 
4 Pus 10 4 No Growth 
2 
days 
4 
2 
days 
5 Urine 8 4 No Growth 
3 
days 
4 
2 
days 
Total 125 22 22 
 
The growth obtained in Kirchner’s liquid medium was indicated by 
turbidity. The generation turn around period in liquid medium was 10 -16 
days and by LJ medium in 21-42 days. Generation was faster in Liquid 
medium when compared to solid LJ medium.  
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TABLE 8 
 
DISTRIBUTION OF MYCOBACTERIUM TUBERCULOSIS 
AND NON TUBERCULOUS MYCOBACTERIUM 
AMONG THE CULTURE POSITIVES 
 
Mycobacteria tuberculosis isolated in cerebrospinal fluid were six, four 
in pleural fluid and Ascitic fluid, only one in the urine samples. There were 
four non-tuberculous Mycobacteria in pus sample and three in urine samples 
 
 
 
S. No 
Types of 
Specimens 
 
Total Specimens
Culture 
 
TB % NTB % 
1 CSF 48 6 12.5 -  
2 PF 44 4 9.1 -  
3 AF 15 4 26.7 -  
4 PUS 10 - - 4 40.0 
5 URINE 8 1 12.5 3 37.5 
TOTAL 125 15  7  
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TABLE 9 
DISTRIBUTION  OF SPECIES IN SPECIMEN POSITIVE FOR 
EXTRAPULMONARY TUBERCULOSIS 
 
Out 22 culture positives 15 samples were mycobacterium tuberculosis 
and seven were non tuberculous mycobacteria. Two of mycobacteria 
fortuitum each  in pus and urine, two  Mycobacterium chelonei were detected 
in pus and one in urine. 
 
 
 
 
 
 
Specimen 
SPECIES ISOLATED 
M.tuberculos M.fortuitum M.chelonel Total  
Cerebro Spinal Fluid 6 - - 6 
Pleural Fluid 4 - - 4 
Ascitic Fluid 4 - - 4 
Pus - 2 2 4 
Urine 1 2 1 4 
Total 15 4 3 22
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TABLE 10 
RESULTS WITH   
LJ CULTURE, Z-N STAIN AND FLUORESCENCE STAIN (N=125) 
 
Result Z_N stain Fluorescence stainCulture positive
Positive 10  (8.0%) 14  (11.20%) 22   (17.6%) 
Negative 115  (92.0%) 111  (88.80%) 103  (82.4%) 
 
The culture positives (17.6 % ) found to be greater than 
smear positives (11.2%). 
 
Table 11 
 
ANTIBIOGRAM 
 
DRUG SUSCEPTIBILITY PATTERNS IN THE CULTURE POSITIVE 
CASES (n=22) 
 
No. of 
Culture 
Positives 
Drug conc. for std. Sensitivity tests 
PNB Response to tests 
Streptomycin INH Rifampicin Ethambutol 
15 < 2μg < 0.2μg < 32 < 2μg Sensitive Sensitive to 
all drugs 
 
PNB – Paranitro benzoic acid   INH - Isoniazid   
 
All the culture positive 15 samples found to be sensitive to first line 
drugs Streptomycin, Isoniazid,  Rifampicin, Ethambutol 
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Table 12 
PCR for Mycobacterium Tuberculosis 
S.No 
 Types of samples 
No of 
samples PCR +ve 
Percentage 
of 
PCR 
1 Cerebrospinal fluid 48 14 29.16 
2 Pleural fluid 44 10 22.72 
3 Ascitic fluid 15 8 53.33 
4 Pus 10 0 - 
5 Urine 8 1 12.50 
 Total 125 33 - 
 
All culture positives were positive by Polymerase chain reaction. 
Eighteen culture negatives were detected as positive by PCR in addition. 
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Table 13 
Results showing comparison of bacteriological investigation with 
Polymerase chain reaction using IS6110 primers coding for 
123 bp of M.tuberculosis genome on various clinical specimens 
S. 
No. 
Type of 
Specimen 
No of 
Specimen
Smear +ve/ 
Culture +ve 
Culture +ve 
/ Smear –ve 
Smear –ve/ 
Culture –ve 
PCR 
+ve 
1 Cerebrospinal fluid 48 4 2 42 14 
2 Pleural fluid 44 3 1 40 10 
3 Ascitic fluid 15 2 2 11 8 
4 Pus 10 3 1 6 0 
5 Urine 8 2 2 4 1 
 Total 125 14 8 103 33 
 
Out of 125 specimen 14 smear and culture positives, 8 were culture 
positive and smear negative. Thirty three samples were found to positive by 
polymerase chain reaction 14 from Cerebrospinal fluid, 10 from Pleural fluid, 
8 from Ascitic fluid and one from Urine. All culture positives are found to be 
positive by Polymerase chain reaction.  
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DISCUSSION 
 
Despite the global importance of tuberculosis, the diagnosis of extra-
pulmonary tuberculosis (EPTB) in its different clinical presentations remains 
a true challenge. Because of acid-staining and mycobacterial culture methods 
has low sensitivity for detecting EPTB, the development and evaluation of 
new diagnostic strategies needed for tuberculosis control programmes. The 
implementation of EPTB diagnostic methods with high specificity and 
sensitivity would improve the isolation of organism from  EPTB patients, and 
should be accelerate the application of appropriate public health control 
measures. 
The present study, a total number of 125 clinically diagnosed EPTB 
patients were included. The period of study was June 2009–May2010. 
Specimens were collected from outpatients as well as inpatients of 
Government Stanley Medical College and Hospital, Chennai. Among the  
125 EPTB cases, 48 were Cerebrospinal fluid, 44 were pleural fluids, 15 were 
Ascitic fluids, 10 were Pus and 8 were Urine samples.  
Samples were subjected to standard methods of diagnosis by smear 
study (fluorescence  &  Ziehl –Neelsen staining), culture on solid medium 
(Lowenstein-Jensen) & Liquid medium (Kirchner’s) and molecular method 
by detection of DNA of mycobacterium Tuberculosis by polymerase chain 
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reaction using IS6110. Drug susceptibility testing  by proportion method was 
done. The results obtained were discussed as follows. 
The average age group in the study was 36.64, which correlated with 
the study done by  Azar Dokht Khosravi et al6 -37.8 years and Soumiesh 
Chakravarthy et al48 and Shafi Ullah  et al48 - 35 years. 
The present  study showed male predominance (68.8%).  The results of 
Meera Sharma et al31  and L.Portillo-Gemez et al 37 (55%) also concorded 
with this study. 
In this study  cerebrospinal fluid 48(38.4%) and Pleural fluid 44 
(35.2%) were predominant followed  by  Ascitic fluid 15 (12%), Pus 
10(8.0%) and Urine 8 (6.0%). It correlates with the study of Lt Col KK Lahiri 
et al25 showed out of 50 samples, cerebrospinal fluid 15(30%) and Pleural 
fluid 11 (22.0%) were predominant followed  by  Ascitic fluid 11 (22.0%), 
Pus 2(4.0%) and Urine 7 (14%) 
By Zeihl- Neelsen staining smear positivity in Cerebrospinal fluid 
samples were three, in Pleural fluid, Pus & Urine samples it was two and one 
in  Ascitic fluid samples. The smear positive by Ziehl-Neelsen staining was 
8% . It  correlates with  Agartha Ani et al2 – 6% and Rajeev Thakur42 et al – 
7.9%  
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Smear positive by fluorescent staining was 11.2 %. In the Indian study 
conducted by Gurung.R. Bhattachariya et al38 showed 5.5%.  The percentage 
of smear positive case by fluorescence staining was found to be greater when 
compared to Ziehl –Neelsen staining.    
 Growth was obtained in LJ medium by 21-42 days. Generation was 
faster in Liquid medium when compared to LJ medium. That correlated with  
study of Susmita Bhattacharya et al50.  
Out of 125 specimen fifteen cultures were positive for Mycobacterium 
tuberculosis among which 6(12.5%) were from cerebrospinal fluid correlate 
with Rajeev Thakur et al42 showed 10.9 % culture positives and  B Sekar et 
al7 showed 17.3 %. 
Out of 44 Pleural fluid samples the culture positivity for 
Mycobacterium tuberculosis was 9%,  B Sekar et al7 showed 12.5 %.  
The Culture positives for Mycobacterium tuberculosis in Ascitic fluid 
was 27%. B Sekar et al7 indicated 19.53 %.  
Out of 8 Urine samples, culture positive for Mycobacterium 
tuberculosis was one (17.5% )  which correlated   Burkina Faso et al studied 
showed culture positive for Mycobacterium tuberculosis was 30.5% , 
There were four culture positives for non-tuberculousMycobacteria in 
pus sample 4(40%) which correlated with the study of  M V Jesudasan et al34 
as 47%.  
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Out of 8 Urine samples, culture positive for non tuberculosis 
Mycobacteria was 3 (37.5% )  which correlated   Burkina Faso et al studied 
showed culture positive for non tuberculous Mycobacteria was 30.5% .  
Among non tuberculous mycobacteria there were 4(18%)  isolates of 
M.fortuitum and 3(13%) isolates of M.chelonei which correlated with study 
of M V Jesudasan et al34   showed M.fortuitum was 35% and 42% of 
M.chelonei were isolated. 
In the present study on comparing with staining, culture  showed more 
positives (17.6%).   
The following reference converges with our study: 
B Sekar et al 7  - 18 %.  
Agartha Ani et al2 – 16%, 
R.Gopal et al40      --19.2 %. 
All culture positives (15)were found to be sensitive  to first line 
antituberculous drugs Streptomycin, Isoniazid,  Rifampicin, Ethambutol. 
All culture positives were found to be positive by IS6110 based PCR . 
18 culture negative samples showed positive in PCR. PCR based assay 
showed more sensitivity than conventional methods. That correlated with   
study of   MENG F. TAN et al32  and   Meera Sharma et al6  . 
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As extra pulmonary specimens were paucibacillary in nature and 
culture takes a long time for growth, PCR assay targeting IS6110 was highly 
useful in the establishment of the diagnosis of EPTB.  
To conclude PCR is a Rapid and Sensitive method in the detection of 
M.tuberculosis from extra-pulmonary specimens. 
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SUMMARY 
 Total number of 125 cases of clinically suspected extra pulmonary 
tuberculosis were included in this study. Specimens were 
Cerebrospinal fluid, Pleural fluid, Ascitic fluid, Pus and Urine. 
 Out of 125 samples 10 (8%)  were found to be positive by Ziehl-
Neelsen and fourteen (11.2%) by Fluorescence staining. 
 Isolation of Mycobacterium tuberculosis was done by standard 
methods.The generation turn around period was 10-16 days in liquid 
medium (Kirchner’s) and 21-42 days in solid medium (Lowenstein-
Jensen). 
 22 samples were found to be positive by culture. 15 cultures were 
positive for Mycobacterium tuberculosis. 7 were positive for non 
tuberculosis Mycobacteria by standard phenotypic methods. 
 Confirmation of Mycobacterium tuberculosis was done by 
susceptibility in L J medium with  para-nitrobenzoic acid, Niacin test 
positive and positive reaction for nitrate reduction. 
 M.fortuitum (4) and M.chelonei (3) were isolated among Non-
Tuberculous Mycobacteria. 
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 All culture positive Mycobacterium tuberculosis were sensitive to first 
line antituberculous drugs -Streptomycin, Isoniazid, Rifampicin, 
Ethambutol. 
 Mycobacterium tuberculosis genomes were found to be positive by 
Polymerase chain reaction using IS6110 primers coding for 123 bp 
from various clinical specimens. 
 Culture positive for non tuberculosis mycobacterium were negative by 
polymerase chain reaction using IS6110 primers. 
 Eighteen smear and culture negative were detected positive by 
polymerase chain reaction using IS6110 primers. 
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CONCLUSION 
 
¾ A high index of suspicion is necessary to  diagnose of Extra Pulmonary 
Tuberculosis 
¾ Delay in diagnosis leads  to sequelae in severe forms of Tuberculosis 
¾ More than one diagnostic procedure is often needed for confirmation 
of the diagnosis, as Extra Pulmonary Specimens were  paucibacillary 
in nature. 
¾ Staining is a rapid method for detection of Mycobacterium 
Tuberculosis but always it should be confirmed with culture in 
Lowenstein-Jensen medium which is the Gold standard conventional 
method. 
¾ Bacteriological and molecular methods aid in correct diagnosis of 
Extra Pulmonary Tuberculosis 
¾ Drug susceptibility on culture positives will detect Multi Drug 
Resistant tuberculosis. 
¾ Mycobacteria grow slowly and replicate every 18-20 hours, so growth 
in culture requires days or weeks. Culture is laborious and time 
consuming.  
¾ The Rapid detection of bacilli with IS6110 based PCR assay is needed 
in management and prevention of complication. 
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MASTER CHART FOR EXTRA PULMONARY SPECIM
 
 
S.No  Patient  Age  Sex  Micro Id  OP/IP Id 
Collection 
Dt 
Specimen  Macroscopic  GRAMS  ZN  Fluorescence  BAP  MAC 
1  Dass  42  male  454/09  18774/09  15‐Jun‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
2  John F kennedy  40  male  472/09  19981/09  15‐Jun‐09  PF  CLEAR  No pus No Orgm‐ve  +ve  +ve  No Growth  No Growth
3  Ebuneshwar  20  male  473/09  063006/09  15‐Jun‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
4  Swetha  32  female  474/09  063106/09  15‐Jun‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
5  Arul raj  25  male  475/09  19871/09  15‐Jun‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
6  Muthuramalingam  55  male  677/09  6356/09 
20‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
7  Mani  40  male  678/09  27319/09 
20‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
8  Solaiyappa  62  male  666/09  27344/09 
21‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
9  Kumar  31  male  682/09  2312/09 
21‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
10  maaboobi  45  female  688/09  28166/09 
24‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
11  Anwar  20  male  690/09  064488/09 
27‐Aug‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
12  Veerabathiran  18  male  694/09  28830/09 
27‐Aug‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
13  Arun  32  male  707/09  29050/09 
28‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
14  Lakshmi  34  female  708/09  27261/09 
28‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
15  Selvarani  38  female  702/09  28593/09 
28‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
16  Chandra sekar  64  male  706/09  64137/09 
28‐Aug‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
17  Antony samy  42  male  709/09  276817/09 
28‐Aug‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
18  Vijay kumar  18  male  710/09  28759/09 
28‐Aug‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
19  Ponammal  38  female  712/09  29210/09 
29‐Aug‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
20  Mahendran  43  male  714/09  29411/09 
29‐Aug‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
21  Sangeetha  27  female  715/09  29381/09 
29‐Aug‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
22  bhavani  18  female  750/09  29855/09  7‐Sep‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
23  viganesh  24  male  752/09  64783/09  7‐Sep‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
24  saravanan  34  male  754/09  30134/09  8‐Sep‐09  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
25  Nithesh  45  male  755/09  64783/09  8‐Sep‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
26  shanmugam  49  male  757/09  30271/09  8‐Sep‐09  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
27  Ramadas  55  male  758/09  24638/09  8‐Sep‐09  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
28  Balaganesh  29  male  800/09  31909/09  21‐Sep‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
29  Amruthavali  31  female  801/09  31809/09  21‐Sep‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
30  Murali  32  male  819/09  31867/09  21‐Sep‐09  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
31  Narayanasamy  33  male  820/09  32468/09  25‐Sep‐09  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
32  Marimuthu  56  male  875/09  32268/09  25‐Sep‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
33  Dhakshi priya  21  female  876/09  34702/09  13‐Oct‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
34  joshuwa  23  male  877/09  34722/09  13‐Oct‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
35  Bharath  34  male  953/09  65485/09 
10‐Nov‐
09 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
36  hari krishanan  35  male  957/09  37909/09 
10‐Nov‐
09 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
37  Sudhakar  37  female  1031/09  42041/09  8‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
38  Raman  19  male  1032/09  42104/09  8‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
39  Kishore  22  male  1070/09  43837/09  12‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  +ve  No Growth  No Growth
40  yuvarani  45  female  1076/09  10930/09  16‐Dec‐09  URINE  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
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41  Selvaraj  41  male  1072/09  43539/09  23‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  +ve  +ve  No Growth  No Growth
42  Margret  35  female  1073/09  43801/09  23‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  +ve  No Growth  No Growth
43  Muniratinam  44  male  1075/09  43827/09  23‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
44  perumal  56  male  1079/09  43223/09  24‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
45  mangammal  60  female  1080/09  43845/09  24‐Dec‐09  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
46 
Lakshmi 
narayanan 
42  male  1083/09  43839/09  24‐Dec‐09  AF  CLEAR  No pus No Orgm‐ve  +ve  +ve  No Growth  No Growth
47  ravi kumar  29  male  1099/09  44231/09  30‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
48  karthick  21  male  1100/09  43252/09  30‐Dec‐09  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
49  kesavan  47  male  1101/09  44267/09  30‐Dec‐09  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
50  doraikannan  40  male  1102/09  44270/09  30‐Dec‐09  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
51  ravi  47  male  1104/09  44281/09  30‐Dec‐09  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
52  kavitha  50  female  1106/09  44147/09  30‐Dec‐09  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
53  rengasamy  70  male  010/10  494/10  6‐Jan‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
54  elavarasan  35  male  011/10  43878/10  6‐Jan‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
55  kesavan  58  male  012/10  67169/10  6‐Jan‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
56  venkatsamy  63  male  023/10  1056/10  11‐Jan‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
57  sakrapani  40  male  067/10  3408/10  2‐Feb‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
58  murgammal  40  female  070/10  3109/10  2‐Feb‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
59  rajendran  55  male  072/10  3541/10  2‐Feb‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
60  srinivasan  50  male  074/10  490/10  2‐Feb‐10  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
61  Lakshmi  19  female  088/10  4945/10  9‐Feb‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
62  thirupati  64  male  090/10  4911/10  9‐Feb‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
63  kalyani  32  female  138/10  6104/10  22‐Feb‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
64  Vijaya  45  female  139/10  6609/09  22‐Feb‐10  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
65  moorthy  31  male  140/10  6621/10  22‐Feb‐10  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
66  vijaybaskar  39  male  141/10  6552/10  25‐Feb‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
67  shanmugam  69  male  149/10  6707/10  25‐Feb‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
68  manimaran  35  male  152/10  6756/10  25‐Feb‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
69  Gokul  42  male  153/10  28977/10  25‐Feb‐10  CSF  CLEAR  No pus No Orgm‐ve  +ve  +ve  No Growth  No Growth
70  Krishnaveni  38  female  158/10  6198/10  28‐Feb‐10  AF  CLEAR  No pus No Orgm‐ve  ‐ve  +ve  No Growth  No Growth
71  vijaya lakshmi  28  female  101/10  2396/10  5‐Mar‐10  PUS  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve 
Opaque 
Colonies 
Opaque 
Colonies 
72  mallika  35  female  102/10  8643/10  8‐Mar‐10  PUS  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve 
Opaque 
Colonies 
Opaque 
Colonies 
73  manavalan  48  male  193/10  8653/10  9‐Mar‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
74  mesanoori  21  female  201/10  8827/10 
10‐Mar‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
75  Simon  28  male  210/10  6502/10 
12‐Mar‐
10 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  +ve  No Growth  No Growth
76  raji  28  female  212/10  5126/10 
13‐Mar‐
10 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
77  narayanan  36  male  213/10  9054/10 
15‐Mar‐
10 
AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
78  palaniyappan  52  male  214/10  9073/10 
15‐Mar‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
79  sekar  46  male  236/10  10013/10 
23‐Mar‐
10 
AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
80  dinesh  24  male  238/10  10108/10 
23‐Mar‐
10 
AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
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81  sudarsan  24  male  239/10  10025/10 
23‐Mar‐
10 
AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
82  Chandra  40  female  252/10  30134/10  2‐Apr‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
83  eshnakumar  48  male  282/10  12077/10  8‐Apr‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
84  Nazeena beevi  32  female  288/10  61922/10  9‐Apr‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
85  Radhakrishnan  48  male  294/10  11918/10  9‐Apr‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
86  Rajadurai  19  male  297/10  12826/10  10‐Apr‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
87  Priya  45  female  300/10  451365/10  10‐Apr‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
88  Vjayalakshmi  30  female  311/10  11235/10  11‐Apr‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
89  yusuf  30  male  313/10  13135/10  11‐Apr‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
90  ragavah  67  male  318/10  12896/10  20‐Apr‐10  CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
91  vanda  19  female  319/10  13523/10  20‐Apr‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
92  paramaguru  24  male  320/10  08692/10  20‐Apr‐10  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
93  narayana  32  male  321/10  13633/10  20‐Apr‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
94  mani kandan  32  male  324/10  22400/10  22‐Apr‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
95  yuvaraj  22  male  325/10  13681/10  22‐Apr‐10  PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
96  sabeetha  30  female  326/10  13679/10  22‐Apr‐10  AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
97  Deepa  29  female  341/10  15348/10 
11‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
98  Shanthi  29  female  342/10  15378/10 
11‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
99  vasantha  32  female  350/10  14356/10 
15‐May‐
10 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
100  jyothi  23  female  361/10  14976/10 
17‐May‐
10 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
101  siddharth  27  male  362/10  62465/10 
17‐May‐
10 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
102  udayashakar  26  male  392/10  17020/10 
17‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
103  veeraragavan  54  male  394/10  16900/10 
17‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
104  thangavelu  55  male  395/10  16845/10 
17‐May‐
10 
AF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
105  Govindasamy  57  male  403/10  17786/10 
19‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
106  Parthiban  23  male  406/10  17858/10 
19‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
107  Elumalai  45  male  404/10  17805/10 
19‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
108  murugan  21  male  415/10  17458/10 
27‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
109  Revathy  26  female  417/10  62978/10 
27‐May‐
10 
CSF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
110  Gopal  20  male  418/10  18348/10 
27‐May‐
10 
PF  CLEAR  No pus No Orgm‐ve  ‐ve  ‐ve  No Growth  No Growth
111  Kala  31  female  11088/09  6519/09  18‐Dec‐09  URINE  CLEAR  No pus No Orgm‐ve  +ve  +ve  No Growth  Growth 
112  Purushothaman  30  male  1135/09  2804/10  26‐Dec‐09  URINE  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
113  Venkatesan  30  male  60/10  2213/10  4‐Jan‐10  URINE  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
114  Jayaraman  36  male  151/10  2415/10  6‐Jan‐10  URINE  CLEAR  No pus No Orgm‐ve  +ve  ‐ve  No Growth  Growth 
115  Santhi  35  female  336/10  961/10  8‐Jan‐10  URINE  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
116  Govindasamy  40  male  1105/10  4126/10  4‐Feb‐10  URINE  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
117  Sundar  40  male  137/10  15761/10  7‐May‐10  URINE  CLEAR  No pus No Orgm‐ve  +ve  ‐ve  No Growth  Growth 
118  Ravi  40  male  957/10  1696/10  1‐Apr‐10  PUS  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
119  Suresh  29  male  955/10  1082/10  1‐Apr‐10  PUS  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
120  Shanmugam  22  male  991/10  3023/10  6‐Apr‐10  PUS  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
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121  Neelan  40  male  1008/10  9288/10  8‐Apr‐10  PUS  CLEAR  No pus No Orgm‐ve  +ve  ‐ve  No Growth  Growth 
122  Paramesvari  21  female  1183/10  13983/10  23‐Apr‐10  PUS  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
123  Madhan kumar  20  male  1433/10  16541/10 
13‐May‐
10 
PUS  CLEAR  No pus No Orgm‐ve  +ve  ‐ve  No Growth  Growth 
124  Valliammal  36  female  1459/10  13687/10 
15‐May‐
10 
PUS  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
125  Mala  30  female  1513/10  17105/10 
21‐May‐
10 
PUS  CLEAR  No pus No Orgm‐ve 
 
‐ve  No Growth  No Growth
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DRUG SENSITIVITY BY PROPORTION METHOD 
S2 dilution           S3 dilution 
   
S4 dilution 
   
Isolate of Mycobacterium tuberculosis was sensitive to First line drugs. 
 
SD – Dihydrostreptomycin 4mg/l 
 
I – Isoniazid 0.2mg/l 
 
R – Rifampicin 40mg/l 
 
E – Ethambutol 2mg/l 
 
PNB – LJ with Para Nitro Benzoic Acid 
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Comparison of Culture Positive by Kirchner’s
and Lowenstein-Jensen Medium 
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Table 10
Results with LJ Culture, Z-N stain  and  Fluorescence Stain(n=125)
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Table 9
Distribution  of Species in specimen positive for 
extra-pulmonary tuberculosis
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Table 13
Results showing comparison of bacteriological investigation with
Polymerase chain reaction using IS6110 primers coding for 123 bp
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PCR for Mycobacteria Tuberculosis
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DRUG SENSITIVITY BY PROPORTION METHOD
100b PC SMC 1 SMC 2 SMC 3 SMC 4 SMC 5 SMC 6p                                  ‐                ‐            ‐              ‐           ‐             ‐       
Agarose Gel Electrophoesis Of IS 6110 Based 
Polymerase Chain Reaction  For Detection Of M.Tuberculosis
From Clinical Specimens   
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